journal article·2022-07-20

Amphiphilic Liquid Crystalline Polymer Micelles That Exhibit a Phase Transition at Body Temperature

Yasuaki Inoue, Kazuhito Takada, Akifumi Kawamura, Takashi Miyata

ACS Applied Materials & Interfaces· Volume 14· Issue 28
Publisher page

Abstract

Liquid crystalline polymers (LCPs), which exhibit unique structures and properties intermediate between those of liquids and solids, are widely utilized as functional and advanced materials for fabricating optical devices and high-performance fibers. This utility stems from their ability to abruptly change their organized structures and mobilities at their liquid crystalline–isotropic phase transition temperatures, similar to the properties of biological membranes. Despite these numerous potential applications of LCPs, no study on their use in medical applications such as drug delivery has been reported. In the present study, we synthesized amphiphilic side-chain LCPs (LCP-g-OEGs, where OEG is oligo(ethylene glycol)) for medical applications, where the LCP-g-OEGs undergo a nematic–isotropic phase transition at body temperature. The LCP-g-OEGs formed micelles with a diameter of approximately 130 nm in aqueous media. The micelles were stable and did not dissociate in aqueous media even when the temperature exceeded the nematic–isotropic phase transition temperature (TNI). Although the release of a dye as a model drug from micelles was suppressed at temperatures lower than TNI, their dye release was drastically enhanced at temperatures higher than TNI. The LCP-g-OEG micelles regulated dye release reversibly in accordance with stepwise changes in temperature, without undergoing dissociation, differing from the behavior of standard temperature-responsive micelles. The temperature-responsive dye release behavior is induced by dramatic changes in their well-organized and dynamic structures as a result of the nematic–isotropic phase transition. These results demonstrate that the LCP-g-OEG micelles have a lot of medical applications as reversibly stimuli-responsive drug carriers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Liquid Crystal Research Advancements · Surfactants and Colloidal Systems · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry and Materials Engineering, Kansai University, 3-3-35, Yamate-cho, Suita, Osaka 564-8680, Japan

Organization for Research and Development of Innovative Science and Technology, Kansai University, 3-3-35, Yamate-cho, Suita, Osaka 564-8680, Japan

Funding

Japan Society for the Promotion of Science · Canon Foundation

References (50)

Show source-provided references
1. 10.1074/jbc.M00364920010.1074/jbc.M003649200 ↗
2. 10.1002/cbic.20040016210.1002/cbic.200400162 ↗
3. 10.1038/252161a010.1038/252161a0 ↗
4. 10.1016/0005-2736(87)90095-210.1016/0005-2736(87)90095-2 ↗
5. 10.1126/science.36465210.1126/science.364652 ↗
6. Weinstein J. N. · Cancer Res. · 1980 · 40 · 1388
7. 10.1016/0005-2736(73)90314-310.1016/0005-2736(73)90314-3 ↗
8. 10.1016/0168-3659(93)90172-210.1016/0168-3659(93)90172-2 ↗
9. 10.1016/S0169-409X(00)00124-110.1016/S0169-409X(00)00124-1 ↗
10. 10.1002/anie.20025065310.1002/anie.200250653 ↗
11. 10.1126/science.107497210.1126/science.1074972 ↗
12. 10.1038/pj.2017.5510.1038/pj.2017.55 ↗
13. 10.1002/anie.20171116310.1002/anie.201711163 ↗
14. 10.1002/adma.20090405910.1002/adma.200904059 ↗
15. 10.1002/marc.1980.03001010710.1002/marc.1980.030010107 ↗
16. 10.1021/ac00280a01910.1021/ac00280a019 ↗
17. 10.1002/bbpc.1990094080710.1002/bbpc.19900940807 ↗
18. 10.1002/marc.1981.03002041310.1002/marc.1981.030020413 ↗
19. 10.1016/j.memsci.2019.11721310.1016/j.memsci.2019.117213 ↗
20. 10.1016/S0169-409X(02)00226-010.1016/S0169-409X(02)00226-0 ↗
21. 10.1002/apmc.1996.05240012310.1002/apmc.1996.052400123 ↗
22. 10.1002/(SICI)1099-0488(199703)35:4<699::AID-POLB16>3.0.CO;2-B10.1002/(SICI)1099-0488(199703)35:4<699::AID-POLB16>3.0.CO;2-B ↗
23. 10.1002/(SICI)1099-0488(19980130)36:2<281::AID-POLB7>3.0.CO;2-U10.1002/(SICI)1099-0488(19980130)36:2<281::AID-POLB7>3.0.CO;2-U ↗
24. 10.1016/S0376-7388(97)00339-610.1016/S0376-7388(97)00339-6 ↗
25. 10.1002/(SICI)1521-3935(19980401)199:4<589::AID-MACP589>3.0.CO;2-610.1002/(SICI)1521-3935(19980401)199:4<589::AID-MACP589>3.0.CO;2-6 ↗
26. 10.1080/02678292.2018.146917110.1080/02678292.2018.1469171 ↗
27. Mariani P. · 1991
28. 10.1016/j.ejpb.2006.11.01010.1016/j.ejpb.2006.11.010 ↗
29. 10.1016/S0142-9612(03)00021-810.1016/S0142-9612(03)00021-8 ↗
30. 10.1021/ja00449a00410.1021/ja00449a004 ↗
31. 10.1021/bm049449110.1021/bm0494491 ↗
32. 10.1016/0003-9861(81)90160-010.1016/0003-9861(81)90160-0 ↗
33. 10.1002/mabi.20090038710.1002/mabi.200900387 ↗
34. 10.1021/bm100561v10.1021/bm100561v ↗
35. 10.1016/j.ijpharm.2005.11.03310.1016/j.ijpharm.2005.11.033 ↗
36. 10.1016/j.ejpb.2020.08.00810.1016/j.ejpb.2020.08.008 ↗
37. Maeda H. · Crit. Rev. Ther. Drug Carrier Syst. · 1989 · 6 · 193
38. 10.1016/j.ijpharm.2011.05.04910.1016/j.ijpharm.2011.05.049 ↗
39. 10.1016/S0079-6700(00)00036-810.1016/S0079-6700(00)00036-8 ↗
40. 10.1517/17425247.5.6.61510.1517/17425247.5.6.615 ↗
41. 10.1038/nmat299210.1038/nmat2992 ↗
42. 10.1021/acs.chemrev.8b0019910.1021/acs.chemrev.8b00199 ↗
43. 10.1038/nmat244210.1038/nmat2442 ↗
44. 10.1016/j.addr.2010.09.00110.1016/j.addr.2010.09.001 ↗
45. Crank J. · 1979
46. 10.1016/j.lwt.2004.07.00410.1016/j.lwt.2004.07.004 ↗
47. 10.1016/j.foodhyd.2014.01.01110.1016/j.foodhyd.2014.01.011 ↗
48. 10.1016/j.lwt.2009.10.00510.1016/j.lwt.2009.10.005 ↗
49. 10.3109/0363904870904015610.3109/03639048709040156 ↗
50. Peppas N. A. · Pharm. Acta Helv. · 1985 · 60 · 110